Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cellular Physiology|December 20, 2008
Effects of MAPK signaling on 1,25-dihydroxyvitamin D-mediated CYP24 gene expression in the enterocyte-like cell line, Caco-2Min Cui, Yan Zhao, Kenneth W Hance, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2009
The antitumor and immunoadjuvant effects of IFN-alpha in combination with recombinant poxvirus vaccinesKenneth W Hance, Connie J Rogers, David A Zaharoff, et al.
Vaccine|August 19, 2008
Exercise enhances vaccine-induced antigen-specific T cell responsesConnie J Rogers, David A Zaharoff, Kenneth W Hance, et al.
The Journal of Nutrition|December 25, 2007
Energy restriction and exercise differentially enhance components of systemic and mucosal immunity in miceConnie J Rogers, David Berrigan, David A Zaharoff, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 27, 2010
Serum adiponectin, leptin, C-peptide, homocysteine, and colorectal adenoma recurrence in the Polyp Prevention TrialGerd Bobe, Gwen Murphy, Connie J Rogers, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2010
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccinationMatteo Vergati, Vittore Cereda, Ravi A Madan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Cutting edge: epigenetic regulation of Foxp3 defines a stable population of CD4+ regulatory T cells in tumors from mice and humansJeremy D Waight, Shinji Takai, Bo Marelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2008
Vaccination with a recombinant Saccharomyces cerevisiae expressing a tumor antigen breaks immune tolerance and elicits therapeutic antitumor responsesElizabeth K Wansley, Mala Chakraborty, Kenneth W Hance, et al.
Cancer Research|July 30, 2009
Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12David A Zaharoff, Benjamin S Hoffman, H Brooks Hooper, et al.
Science Translational Medicine|January 19, 2018
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-βYan Lan, Dong Zhang, Chunxiao Xu, et al.
Pageof 3